Are CME providers being used by the pharmaceutical industry to legitimize a treatment for a condition that isn’t really a disease? Did GlaxoSmithKline “invent” irritable bowel syndrome in part by underwriting CME on the subject? These uncomfortable questions have been raised in a new article appearing in the April 13 issue of the British Medical Journal. A lot of money can be made from healthy people who believe they are sick. Pharmaceutical companies sponsor diseases and promote them to ...

Register for Complete Access (Valid Email Required)

By registering on MeetingsNet now, you'll not only gain access to Printer-friendly, you'll get exclusive access to a large archive of premium content.

Already registered? here.